IHS Chemical Week

People & Business :: M&A

GSK to spend $1 billion on raising stake in Indian subsidiary

7:42 AM MST | December 16, 2013 | Natasha Alperowicz

GlaxoSmithKline (GSK) today announced an offer to increase its stake in its publicly listed pharmaceutical subsidiary in India, GlaxoSmithKline Pharmaceuticals Ltd., from 50.7% to 75% at a price of 3,100 Indian rupee/share ($50.21). GSK intends to keep the company listed. Securities regulations in India require a minimum public shareholding of 25% for a company to maintain a public listing.   The offer is for the acquisition of up to 20,609,775 shares, representing 24.3% of the total outstanding shares of the Indian company. The offer represents a premium of...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa